Anyone who had been patient enough and build a position under .09 the past couple of weeks was rewarded today. The stock gaped up 15%.

ACTC Technology has been recently featured in USA Today, Newsweek, and Scientific American. My guess is that a few reporters at the recent Insurance Linked Securities Summit took notice of ACTC's operations and wanted to dig a little deeper into the stem cell world.